Chairman Hendrix Genetics’ International Advisory Board Retires

Published on April 25, 2017

Chairman Hendrix Genetics’ International Advisory Board Retires

Richard van Wijnbergen has retired as Chairman of the International Advisory Board (IAB) of Hendrix Genetics on April 20, 2017. He will be succeeded by Aalt Dijkhuizen, member of the board since 2007. 

Richard’s ten years of leadership has contributed to Hendrix Genetics’ current market position. Under his inspiring chairmanship, Hendrix Genetics has grown into a global leader in multi-species animal genetics and research. 

Thijs Hendrix

We are thankful to Richard for his advice over the past ten years and for his contribution to the success of our company. We wish him well for the future.

Thijs Hendrix
Thijs Hendrix
Président, Hendrix Genetics

Appointment Aalt Dijkhuizen

With his extensive knowledge in agriculture, research and business processes Aalt Dijkhuizen, being member of the IAB for many years already, will replace Richard van Wijnbergen as Chairman of the IAB of Hendrix Genetics. Together with the other members of the IAB: Johan Terpstra, on behalf of shareholder NPM Capital N.V. (part of SHV Holdings N.V.), and Cyril Melin, on behalf of shareholder Sofiprotéol S.A. the board will continue to provide guidance and support to the company’s Executive Board and Management Committee.

Related articles

, by
Hendrix Genetics secures grant to provide affordable, high-quality chickens to African farmers

Hendrix Genetics receives grant from the Bill & Melinda Gates Foundation to develop and deliver chickens that will improve the lives of small-scale African poultry farmers.

, by
Researchers uncover new turkey genome sequence

A recent study from the Wageningen University & Research and Hendrix Genetics (Hybrid Turkeys) has uncovered a new sequence of the turkey genome.

, by
Position Statement on Gene Editing

Gene editing* is a rapidly developing technology with many potential applications, including in animal genetics. Hendrix Genetics does not currently use any form of gene editing but has made investme…